Testosterone, Metformin, or Both, for Hypogonadism in Obese Males
Status:
Completed
Trial end date:
2016-07-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of metformin, testosterone, or both, in
males with obesity-related hypogonadism. This study will evaluate changes in insulin
resistance, weight loss, body composition, testosterone levels,quality of life and erectile
dysfunction.
Obese men will receive diet and physical activity counselling, and be randomised to either
testosterone, metformin, a combination of both or placebo
Phase:
Phase 3
Details
Lead Sponsor:
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud